Abstract
Thymoquinone (THQ), the active constituent of Nigella sativa seeds, has demonstrated some potential pharmacological activities. The present study was designed to investigate the pharmacokinetic behavior of THQ following intravenous (IV) and oral (PO) administration using an animal model. THQ was given vascularly (5 mg/kg IV) and extravascularly (20 mg/kg PO) to Vole rabbits, and blood samples were collected at predetermined time points. The concentrations of THQ in plasma were measured by a high-performance liquid chromatography, and the pharmacokinetic parameters were determined using both compartmental and non-compartmental analyses. The calculated clearance (CL) following IV administration was 7.19 ± 0.83 ml/kg/min, and the estimated volume of distribution at steady state (V ss) was 700.90 ± 55.01 ml/kg. Whereas with PO dosing, apparent CL/F value was 12.30 ± 0.30 ml/min/kg and V ss/F was 5,109.46 ± 196.08 ml/kg. These parameters were associated with an elimination half-life (T 1/2) of 63.43 ± 10.69 and 274.61 ± 8.48 min with IV and PO dosing, respectively. The calculated absorption T 1/2 was about 217 min. Compartmental analysis revealed T 1/2α of ~8.9 min and T 1/2β of ~86.6 min. The calculated absolute bioavailability of THQ was ~58 % with a lag time of ~23 min. The estimated THQ protein binding was >99 %. Therefore, THQ represents a compound with rapid elimination and relatively slower absorption following PO administration.
Similar content being viewed by others
References
Al-Ghamdi MS (2001) Anti-inflammatory, analgesic and anti-pyretic activity of Nigella sativa. J Ethnopharmacol 76:45–48
Aljabre SHM, Randhawa MA, Akhtar N, Alakloby OM, Alqurashi AM, Aldossary A (2005) Antidermatophyte activity of ether extract of Nigella sativa and its active principle, THQ. J Ethnopharmacol 101:116–119
Alkharfy KM, Al-Daghri NM, Al-Attas OS, Alokail MS (2011) The protective effect of thymoquinone against sepsis syndrome morbidity and mortality in mice. Int Immunopharmacol 11(2):250–254
Alkharfy KM, Ahmad A, Khan RMA, Al-Asmari M (2013) High performance liquid chromatography of THQ in rabbit plasma and its application to pharmacokinetics. J Liq Chromatogr Rel Technol 36:2242–2250
Badary OA, Gamal El-din AM (2001) Inhibitory effect of THQ against 20-methylchlolanthrene-induced fibrosarcoma tumorigenesis. Cancer Detect Prev 25:362–368
Bamosa AO, Ali BA, Sowayan SA (1997) Effect of PO ingestion of Nigella sativa seed on some blood parameters. Saudi Pharm J 5:126–129
Burits M, Bucar F (2000) Antioxidant activity of Nigella sativa essential oil. Phytother Res 14:323–328
El-Dakhakhany M (1963) Studies on the chemical constitution of Egyptian N. sativa L. seeds. Plant Med 11:465–470
El-Kadi A, Kandil O (1986) Effect of Nigella sativa (the black seed) on immunity. In: Proceeding of the 4th International Conference on Islamic Medicine, Kuwait. Bull Islamic Med vol 4, pp 344–348
McDonald FE, Reddy KS (2001) Convergent synthesis of digitoxin: stereo selective synthesis and glycosylation of the digoxin trisaccharide glycal. Angew Chem Int Ed 40:3653–3655
Pacifici GM, Viani A (1992) Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences. Clin Pharmacokinet 23(6):449–468
Pan L, Chai HB, Kinghorn AD (2012) Discovery of new anticancer agents from higher plants. Front Biosci (Schol Ed) 4:142–156
Ragheb A, Attia A, Eldin WS (2009) The protective effect of THQ, an anti-oxidant and anti-inflammatory agent, against renal injury: a review. Saudi J Kidney Dis Transpl 20:741–752
Vuorelaa P, Leinonenb M, Saikkuc P, Tammelaa P, Rauhad JP, Wennberge T, Vuorela H (2004) Natural products in the process of finding new drug candidates. Current Med Chem 11:1375–1389
Wright JD, Boudinot FD, Ujhelyi MR (1996) Measurement and analysis of unbound drug concentrations. Clin Pharmacokinet 30:445–462
Yáñez1 JA, Remsberg CM, Sayre CL, Forrest ML, Davies NM (2011). Flip-flop pharmacokinetics: delivering a reversal of disposition: challenges and opportunities during drug development. Ther Deliv 2(5):643–672
Acknowledgments
The authors would express their appreciation to the Prince Mutaib Chair for Biomarkers of Osteoporosis for their scientific support.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Alkharfy, K.M., Ahmad, A., Khan, R.M.A. et al. Pharmacokinetic plasma behaviors of intravenous and oral bioavailability of thymoquinone in a rabbit model. Eur J Drug Metab Pharmacokinet 40, 319–323 (2015). https://doi.org/10.1007/s13318-014-0207-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13318-014-0207-8